Thank you for attending the GSK-sponsored scientific symposia on infectious diseases

Scientific sessions organised and funded by GSK for healthcare professionals.

GSK product data mentioned.

Thank you
on behalf of GSK!
It was great to see you at ESCMID Global

Dear ESCMID Global attendees,

Thank you for your attendance at the ESCMID Global Congress (formerly ECCMID), we hope you enjoyed the GSK-led scientific sessions and booth events.

The ESCMID Global Congress provided the perfect opportunity for us to showcase our commitment to getting ahead of infectious diseases with our focus on prevention and treatment. Please click the following links to explore the disease area and treatment landscape of Urinary Tract Infections (UTIs) and Vaccine-Preventable Diseases.

Urinary Tract Infections (UTIs)

Vaccine-Preventable Diseases

We hope you had the opportunity to attend one or more of our scientific sessions and our booth at the ESCMID Global Congress 2024.

In case you missed it, our Symposia and Innovation and Pipeline Theater sessions will be available on-demand via the ESCMID Global Platform soon.
We will be sharing additional information on how to access these sessions in a subsequent communication.

Please do not forward.

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on +44(0)800 221 441 or UKSafety@gsk.com

Scientific dissemination is based on published and accessible data and has an informative/educational purpose. To this end, the data is presented faithfully reflecting scientific publications without any modification or addition. Its content is protected by copyright and may not be reproduced (photo, recording or 'screen prints'), nor disclosed or transmitted to any third party by any means, without the written authorization of GSK.

La divulgación científica está basada en datos publicados y accesibles y tiene una finalidad informativa/formativa. A tal efecto, los datos se presentan reflejando fielmente las publicaciones científicas sin ninguna modificación o añadido. Su contenido está protegido por derechos de autor y no puede ser reproducido (foto, grabación o 'impresiones de pantalla’), ni divulgado ni transmitido a ningún tercero por cualquier medio, sin la autorización escrita de GSK.

NX-GBL-CEP-COCO-240001 | April 2024

You have received this email as a contact of ESCMID or one of its affiliated societies.
You can unsubscribe here.